Sort   by:  
 Page size 
UnknownImproved resilience and proteostasis mediate longevity upon DAF-2 degradation in old age.
Not available
S-EPMC11335714 | biostudies-literature
UnknownEffect of Sickle Cell Trait and APOL1 Genotype on the Association of Soluble uPAR with Kidney Function Measures in Black Americans.
Not available
S-EPMC7863645 | biostudies-literature
UnknownImmunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease
Not available
S-EPMC12133910 | biostudies-literature
UnknownComparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies.
Not available
S-EPMC6389727 | biostudies-literature
UnknownRegional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial.
Not available
S-EPMC12260115 | biostudies-literature
UnknownAmyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease.
Not available
S-EPMC9828339 | biostudies-literature
UnknownLongitudinal head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease.
Not available
S-EPMC10330155 | biostudies-literature
UnknownDownstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial.
Not available
S-EPMC11059071 | biostudies-literature
UnknownInherited causes of clonal haematopoiesis in 97,691 whole genomes.
Not available
S-EPMC7944936 | biostudies-literature
UnknownThe genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals.
Not available
S-EPMC5042863 | biostudies-literature
Sort   by:  
 Page size